發(fā)布時間：2018-06-20 00:07

  本文選題：GPR119 + β-arrestin��； 參考：《昆明理工大學(xué)》2014年碩士論文

【摘要】：GPR119屬于G蛋白偶聯(lián)受體A型家族,主要在腸道內(nèi)分泌L細(xì)胞和胰腺β細(xì)胞表面表達(dá),當(dāng)GPR119被激活后能夠直接促進(jìn)L細(xì)胞分泌GLP-1,并引發(fā)GLP-1的全部生理功能,同時也能夠直接促進(jìn)β細(xì)胞分泌胰島素。因此,GPR119成為近年來研究糖尿病治療的新靶點(diǎn)。而以GPR119分子藥理學(xué)及其生物學(xué)特征為基礎(chǔ),建立相應(yīng)的藥物篩選模型并尋找GPR119小分子調(diào)節(jié)劑是抗糖尿病研發(fā)的新途徑。本研究將以GPR119為靶點(diǎn),通過直接或間接標(biāo)記該靶點(diǎn)構(gòu)建熒光標(biāo)記的穩(wěn)定細(xì)胞株,為下一步開展天然產(chǎn)物的藥物篩選(尤其是小分子)奠定基礎(chǔ)。本研究首先構(gòu)建了GPR119綠色熒光蛋白(GFP)標(biāo)記的真核表達(dá)載體,并先后轉(zhuǎn)染人骨肉瘤U20S細(xì)胞和HEK293細(xì)胞,初步獲得熒光標(biāo)記的GPR119轉(zhuǎn)染細(xì)胞,并利用蛋白質(zhì)印跡技術(shù)驗(yàn)證了瞬時轉(zhuǎn)染成功和GPR119蛋白的表達(dá)。但轉(zhuǎn)染細(xì)胞在未加激動劑刺激情況下,也能發(fā)生自聚集反應(yīng)。在后續(xù)實(shí)驗(yàn)中,經(jīng)抗性篩選后轉(zhuǎn)染細(xì)胞均全部死亡,難以形成穩(wěn)定的細(xì)胞系,針對可能的原因,設(shè)計了多種解決方案,包括更換細(xì)胞類型、排除血清干擾、加入鈣離子抑制劑、降低轉(zhuǎn)染時的質(zhì)粒濃度等,效果均不明顯,仍在繼續(xù)尋找合理的原因�？紤]到GFP分子量較大,直接標(biāo)記GPR119可能影響其空間結(jié)構(gòu),造成建立熒光標(biāo)記GRP119細(xì)胞株的困難。而β-arrestin在G蛋白偶聯(lián)受體信號轉(zhuǎn)導(dǎo)中發(fā)揮著重要作用,它能特異性地與被配體激活的受體復(fù)合物結(jié)合,因此通過熒光標(biāo)記的β-arrestin也能檢測GPR119的聚合。因此,利用本實(shí)驗(yàn)室已構(gòu)建的熒光標(biāo)記β-arrestin的細(xì)胞株,嘗試引入表達(dá)天然構(gòu)象的GPR119建立相應(yīng)的篩藥細(xì)胞株。實(shí)驗(yàn)選用整合型質(zhì)粒pCMV6-A-Hygro,插入GPR119序列,構(gòu)建了pCMV6-A-Hygro-GPR119質(zhì)粒并轉(zhuǎn)染了熒光標(biāo)記β-arrestin細(xì)胞株,加入激動劑后,已觀察到熒光聚集,經(jīng)過分選有望獲得穩(wěn)定細(xì)胞株。本研究通過直接標(biāo)記和間接標(biāo)記技術(shù)構(gòu)建穩(wěn)定的GPR119細(xì)胞株,兩種方法均已得到瞬時表達(dá)的重組細(xì)胞,其中間接標(biāo)記細(xì)胞能與激動劑發(fā)生反應(yīng)。本研究為今后篩選小分子GPR119激動劑和其它調(diào)節(jié)劑提供了基礎(chǔ)。
[Abstract]:GPR119 belongs to the G protein-coupled receptor A family, mainly expressed on the surface of endocrine L cells and pancreatic 尾 cells. When GPR119 is activated, it can directly promote the secretion of GLP-1 by L cells and trigger the whole physiological function of GLP-1. At the same time, it can also directly promote the secretion of insulin by 尾-cells. Therefore, GPR119 has become a new target for the treatment of diabetes in recent years. Based on the molecular pharmacology and biological characteristics of GPR119, it is a new way to develop anti-diabetic drugs to establish the corresponding drug screening model and find the small molecular regulator of GPR119. In this study, GPR119 was used as the target to construct the fluorescent labeled stable cell line by directly or indirectly labeling the target, which laid the foundation for drug screening of natural products (especially small molecules) in the next step. In this study, a GPR119 green fluorescent protein (GFP) labeled eukaryotic expression vector was constructed and transfected into human osteosarcoma U20S cells and HEK293 cells, and fluorescent labeled GPR119 transfected cells were obtained. The transient transfection and the expression of GPR119 protein were verified by Western blot. However, the transfection cells also showed a self-aggregation reaction without agonist stimulation. In the subsequent experiments, all the transfected cells died after the resistance screening, and it was difficult to form a stable cell line. According to the possible reasons, a variety of solutions were designed, including changing cell types, eliminating serum interference, and adding calcium ion inhibitors. The effect of reducing plasmid concentration during transfection was not obvious. Considering the high molecular weight of GFP, the direct labeling of GPR119 may affect its spatial structure and make it difficult to establish a fluorescent labeled GRP119 cell line. 尾 -arrestin plays an important role in the signal transduction of G-protein-coupled receptor, and it can specifically bind to ligand-activated receptor complex. Therefore, 尾 -arrestin can also detect the polymerization of GPR119 by fluorescent labeled 尾 -arrestin. Therefore, using the fluorescent labeled 尾 -arrestin cell line constructed in our laboratory, we try to introduce the natural conformation of GPR119 to establish the corresponding screening cell line. The plasmid pCMV6-A-Hygro119 was inserted into the GPR119 sequence. The plasmid pCMV6-A-Hygro-GPR119 was constructed and transfected into the fluorescent labeled 尾 -arrestin cell line. After the addition of agonist, fluorescence aggregation was observed, and the stable cell line was expected to be obtained by sorting out the pCMV6-A-Hygro-GPR119. In this study, a stable GPR119 cell line was constructed by direct and indirect labeling techniques. Both methods have obtained transient expression of recombinant cells, in which indirect labeled cells can react with agonists. This study provides a basis for screening small molecule GPR119 agonists and other regulators in the future.
【學(xué)位授予單位】：昆明理工大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2014
【分類號】：R96

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 王奕江,王云龍,馮靜,李晨陽,路江濤,姜納新;核酸探針的熒光標(biāo)記初探[J];中國衛(wèi)生檢驗(yàn)雜志;1999年06期

2 王剛石,王孟薇,尤緯締,王宏芳,豐美福;熒光標(biāo)記mRNA差異顯示技術(shù)[J];中國應(yīng)用生理學(xué)雜志;2000年04期

3 車發(fā)云,夏其昌;磷酸化底物肽的硫代磷酸化及熒光標(biāo)記[J];生物化學(xué)與生物物理學(xué)報;2000年01期

4 王琴,靳大慶,李佑英,程建波;人體脫落上皮細(xì)胞的熒光標(biāo)記STR分型[J];法律與醫(yī)學(xué)雜志;2004年01期

5 李隆云;熒光標(biāo)記分析及其在中藥材中的應(yīng)用[J];時珍國醫(yī)國藥;1998年04期

6 劉瀍雯;何怡青;楊翠霞;龍莉;高鋒;;熒光標(biāo)記電泳對透明質(zhì)酸寡糖片段鑒定的方法建立[J];中國生物化學(xué)與分子生物學(xué)報;2007年07期

7 楊軍慧,蔣瑞華;加熱法快速進(jìn)行T-HCl熒光標(biāo)記精子的研究[J];刑事技術(shù);1994年04期

8 張毅;高星杰;付雪;蘇超;史雪彬;段中潮;付曉;何津巖;楊潔;;活細(xì)胞內(nèi)人AGTR1-3′UTR的熒光標(biāo)記及應(yīng)激定位分析[J];中國細(xì)胞生物學(xué)學(xué)報;2014年05期

9 莊明華,白曄,高立達(dá),李明遠(yuǎn),牟家婉,何俊,李勇,蔣忠華,東云華;抗人腦膠質(zhì)瘤單克隆抗體H_(12)的熒光標(biāo)記[J];汕頭大學(xué)醫(yī)學(xué)院學(xué)報;2001年04期

10 王飛;劉珍;許桂鳳;侯娟;張?zhí)鞂?;熒光標(biāo)記對納米聚苯乙烯細(xì)胞毒性和細(xì)胞內(nèi)變化過程的影響[J];衛(wèi)生研究;2010年05期

相關(guān)會議論文 前3條

1 袁景利;王桂蘭;譚明乾;葉志強(qiáng);;稀土熒光標(biāo)記材料[A];第十五次全國色譜學(xué)術(shù)報告會文集（上冊）[C];2005年

2 姜先華;劉鋒;沈紅纓;于蛟;;熒光標(biāo)記法陳舊性骨骼的mtDNA序列分析技術(shù)[A];第二次全國法醫(yī)物證學(xué)學(xué)術(shù)交流會論文集[C];1998年

3 鄭金云;王燕麗;廖新成;趙玉芬;;新型熒光標(biāo)記核苷及核酸的合成及應(yīng)用研究[A];中國化學(xué)會第四屆有機(jī)化學(xué)學(xué)術(shù)會議論文集（下冊）[C];2005年

相關(guān)重要報紙文章 前1條

1 張巍巍;無需熒光標(biāo)記也能檢測基因[N];科技日報;2012年

相關(guān)碩士學(xué)位論文 前3條

1 劉鴻飛;熒光標(biāo)記GPR119細(xì)胞系的構(gòu)建[D];昆明理工大學(xué);2014年

2 韓章潤;多糖熒光標(biāo)記及運(yùn)用糖芯片研究糖與蛋白相互作用[D];中國海洋大學(xué);2011年

3 努爾買買提·庫達(dá)巴爾地;甲硝唑等四種藥物的熒光標(biāo)記及其分析應(yīng)用[D];新疆大學(xué);2012年

，

本文編號：2041961